Investing
BioNTech, CyberArk, Vertex Pharma and More Monday Afternoon Analyst Calls
Published:
With the trading day closing in on the halfway point, traders were feeling the heat as all the major indexes were ripping downward. The Dow Jones industrials were seeing the worst of it, down over 2% midday. The earnings season crush is on this week, with major earnings like Netflix on the menu. It is yet to be seen if these can make any change in trajectory for the broad markets.
24/7 Wall St. is reviewing some big analyst calls seen on Monday. We have included the latest analyst call on each stock, as well as a recent trading history and the consensus targets among analysts.
For those that might have missed it, 24/7 Wall St. had an earlier round of analyst calls on Monday that included ADT, Alcoa, GoDaddy, KB Home, Morgan Stanley and Qualcomm.
Acceleron Pharma Inc. (NASDAQ: XLRN): Wolfe Research resumed coverage with an Outperform rating and a $183 price target. The shares were changing hands at around $118 apiece on Monday, in a 52-week trading range of $85.58 to $146.15.
BioNTech S.E. (NASDAQ: BNTX): Wolfe Research resumed coverage with an Outperform rating and a $248 price target. The stock was changing hands at around $236 a share on Monday, in a 52-week range of $54.10 to $252.78.
BJ’s Wholesale Club Holdings Inc. (NYSE: BJ): Argus resumed coverage with a Hold rating. The stock traded near $47 on Monday, in a 52-week range of $36.07 to $50.18. It has a consensus price target of $52.50.
CyberArk Software Ltd. (NASDAQ: CYBR): Colliers Securities upgraded the stock to a Buy rating from Neutral and has a $165 price target. The stock traded near $134 on Monday, in a 52-week range of $95.12 to $169.70. It has a consensus price target of $173.61.
Five9 Inc. (NASDAQ: FIVN): Needham downgraded it to Hold from Buy. The stock was changing hands around $186 a share on Monday, in a 52-week range of $107.77 to $201.75.
Talkspace Inc. (NASDAQ: TALK): William Blair initiated with an Outperform rating. The stock traded near $6 on Monday, in a 52-week range of $5.44 to $12.45.
Vertex Pharmaceuticals Inc. (NASDAQ: VRTX): Wolfe Research resumed coverage with an Outperform rating and a $252 price target. The stock traded at around $200 a share on Monday, in a 52-week range of $185.33 to $304.00.
Wix.com Ltd. (NASDAQ: WIX): Morgan Stanley initiated coverage with an Overweight rating and a $339 price target. It traded near $287 a share on Monday, in a 52-week range of $213.12 to $362.07. The consensus price target is $323.05.
24/7 Wall St.Four of the semiconductor industry’s best companies are top stock picks at Jefferies, and aggressive growth investors looking for an alpha upside boost for the rest of the summer may want to consider positions.
The #1 Thing to Do Before You Claim Social Security (Sponsor)
Choosing the right (or wrong) time to claim Social Security can dramatically change your retirement. So, before making one of the biggest decisions of your financial life, it’s a smart idea to get an extra set of eyes on your complete financial situation.
A financial advisor can help you decide the right Social Security option for you and your family. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you.
Click here to match with up to 3 financial pros who would be excited to help you optimize your Social Security outcomes.
Have questions about retirement or personal finance? Email us at [email protected]!
By emailing your questions to 24/7 Wall St., you agree to have them published anonymously on a673b.bigscoots-temp.com.
By submitting your story, you understand and agree that we may use your story, or versions of it, in all media and platforms, including via third parties.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
